Toll Free: 1-888-928-9744
Published: May, 2014 | Pages:
21 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Wellstat Vaccines, LLC - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Wellstat Vaccines, LLC - Product Pipeline Review - 2014', provides an overview of the Wellstat Vaccines, LLC's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Wellstat Vaccines, LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Wellstat Vaccines, LLC including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Wellstat Vaccines, LLC's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Wellstat Vaccines, LLC's pipeline products Reasons to buy - Evaluate Wellstat Vaccines, LLC's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Wellstat Vaccines, LLC in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Wellstat Vaccines, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Wellstat Vaccines, LLC and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Wellstat Vaccines, LLC - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Wellstat Vaccines, LLC and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Wellstat Vaccines, LLC Snapshot 4 Wellstat Vaccines, LLC Overview 4 Key Information 4 Key Facts 4 Wellstat Vaccines, LLC - Research and Development Overview 5 Key Therapeutic Areas 5 Wellstat Vaccines, LLC - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Wellstat Vaccines, LLC - Pipeline Products Glance 9 Wellstat Vaccines, LLC - Early Stage Pipeline Products 9 Preclinical Products/Combination Treatment Modalities 9 Discovery Products/Combination Treatment Modalities 10 Wellstat Vaccines, LLC - Drug Profiles 11 Candidiasis Vaccine 11 Product Description 11 Mechanism of Action 11 R&D Progress 11 Meningococcus CY Polysaccharide Conjugate Vaccine 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 Group A Streptococcus Vaccine 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 Group B Streptococcus Vaccine 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 Meningococcus B Vaccine 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 Pneumococcus Pneumolysoid Conjugate Vaccine 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Wellstat Vaccines, LLC - Pipeline Analysis 17 Wellstat Vaccines, LLC - Pipeline Products by Target 17 Wellstat Vaccines, LLC - Pipeline Products by Molecule Type 18 Wellstat Vaccines, LLC - Locations And Subsidiaries 19 Head Office 19 Appendix 20 Methodology 20 Coverage 20 Secondary Research 20 Primary Research 20 Expert Panel Validation 20 Contact Us 21 Disclaimer 21
List of Tables Wellstat Vaccines, LLC, Key Information 4 Wellstat Vaccines, LLC, Key Facts 4 Wellstat Vaccines, LLC - Pipeline by Indication, 2014 6 Wellstat Vaccines, LLC - Pipeline by Stage of Development, 2014 7 Wellstat Vaccines, LLC - Monotherapy Products in Pipeline, 2014 8 Wellstat Vaccines, LLC - Preclinical, 2014 9 Wellstat Vaccines, LLC - Discovery, 2014 10 Wellstat Vaccines, LLC - Pipeline by Target, 2014 17 Wellstat Vaccines, LLC - Pipeline by Molecule Type, 2014 18
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.